Hepatitis B vaccination for patients with chronic renal failure (Q24246719)

Europe PubMed Central

title

Hepatitis B vaccination for patients with chronic renal failure (English)

0 references

1 reference

James M Zacharias

7

0 references

author name string

Robert J Schroth

1

0 references

Carol A Hitchon

2

0 references

Julia Uhanova

3

0 references

Ayman M Noreddin

4

0 references

Shayne P Taback

5

0 references

Michael Moffatt

Cochrane Database of Systematic Reviews

6

0 references

publication date

19 July 2004

0 references

published in

0 references

cites work

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Hepatitis B vaccines in patients with chronic renal failure before dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Hepatitis B virus infection in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

HBV-vaccination in recipients of kidney allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Hepatitis in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

The use of vaccines in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

National surveillance of dialysis-associated diseases in the United States, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Hepatitis B and hepatitis delta virus infection in South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Meta-style and expert review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Immunogenicity of recombinant hepatitis B vaccine in dialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Immunogenicity of the recombinant GenHevac B Pasteur vaccine against hepatitis B in chronic uremic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

National surveillance of dialysis associated diseases in the United States, 1995

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Novel evidence on hepatitis B virus infection in dialysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Lower long-term efficiency of intradermal hepatitis B vaccine compared to the intramuscular route in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021

Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003775.PUB2

7 January 2021